← Leaderboards
Ramin V Parsey
Columbia University Health Sciences
$13,126,286
Attributed
$21,744,627
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,744,627 · 10
By mechanism
R01$11,115,711 · 4
U01$8,942,332 · 1
K08$854,543 · 1
R21$438,625 · 1
M01$385,820 · 1
P41$7,596 · 2
Top collaborators
- Christine Delorenzo11 shared
- Patrick J Mc Grath10 shared
- Myrna M Weissman10 shared
- Lee M Ritterband1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Daniel Peter Petrylak$378,547
- Gregory M Sullivan$6,067,274
- M Elizabeth Sublette$5,097,802
- Ying Kuen Cheung$5,353,578
- Jason Wright$4,496,895
Others in their field
Top investigators on “Disease Remission”
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$146,545,242
- Judith S. Currier · University Of California Los Angeles$138,385,972
- James E. Gern · University Of Wisconsin-Madison$117,345,848
- Sharon A Nachman · Johns Hopkins University$77,468,129
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Grace M. Aldrovandi · University Of California Los Angeles$69,942,714
Research focus
Disease RemissionPharmaceutical PreparationsPositron-Emission TomographyResponseMental DepressionBrainMajor Depressive DisorderAntidepressive AgentsDepressive SymptomsMolecularChronicIn VivoPrefrontal CortexAftercareSelective Serotonin Reuptake InhibitorDepressed MoodBinding (Molecular Function)InterestBaseBiologicalFunctional DisorderTreatment OutcomePathologyReporting
Grant awards (44)
Mechanistic clinical trial evaluating the role of the metabotropic glutamate receptor subtype 5 (mGluR5) in the antidepressant mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)$808,417
R01 · FY2025 · MH
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$696,610
R01 · FY2024 · MH · contact PI
Preliminary imaging studies evaluating the vesicular acetylcholine transporter as a treatment target in major depressive disorder$438,625
R21 · FY2024 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$70,608
R01 · FY2024 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$699,730
R01 · FY2023 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention - Diversity Administrative supplement for Kimberly Nnah$70,608
R01 · FY2023 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$689,078
R01 · FY2022 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$49,340
R01 · FY2022 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$762,135
R01 · FY2021 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$21,899
R01 · FY2021 · MH · contact PI
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention$737,050
R01 · FY2020 · MH · contact PI
Lithium's Molecular Mechanism of Action and the Pathology of Bipolar Disorders$804,734
R01 · FY2015 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$457,863
U01 · FY2015 · MH
Supplement to Lithium's Molecular Mechanism of Action and the Pathology of Bipolar Disorders$145,985
R01 · FY2015 · MH · contact PI
Lithium's Molecular Mechanism of Action and the Pathology of Bipolar Disorders$848,704
R01 · FY2014 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$1,792,950
U01 · FY2013 · MH
Lithium's Molecular Mechanism of Action and the Pathology of Bipolar Disorders$817,018
R01 · FY2013 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$141,638
U01 · FY2013 · MH
Biosignatures of Treatment Remission in Major Depression$1,778,562
U01 · FY2012 · MH
Lithium's Molecular Mechanism of Action and the Pathology of Bipolar Disorders$856,791
R01 · FY2012 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$548,996
U01 · FY2012 · MH
Biosignatures of Treatment Remission in Major Depression$41,673
U01 · FY2012 · MH
Biosignatures of Treatment Remission in Major Depression$29,926
U01 · FY2012 · MH
Biosignatures of Treatment Remission in Major Depression$1,807,205
U01 · FY2011 · MH
Lithium's Molecular Mechanism of Action and the Pathology of Bipolar Disorders$724,986
R01 · FY2011 · MH · contact PI
Biosignatures of Treatment Remission in Major Depression$614,421
U01 · FY2011 · MH
Biosignatures of Treatment Remission in Major Depression$1,729,098
U01 · FY2010 · MH
Biological Predictors of Response to Antidepressants$450,082
R01 · FY2010 · MH · contact PI
Biological Predictors of Response to Antidepressants$465,701
R01 · FY2009 · MH · contact PI
Biological Predictors of Response to Antidepressants$460,502
R01 · FY2008 · MH · contact PI
DEPRESSION STUDY$2,576
P41 · FY2008 · RR · contact PI
Biological Predictors of Response to Antidepressants$467,886
R01 · FY2007 · MH · contact PI
DEPRESSION STUDY$5,020
P41 · FY2007 · RR · contact PI
Biological Predictors of Response to Antidepressants$467,847
R01 · FY2006 · MH · contact PI
Imaging of Serotonin Transporters in Depression$171,162
K08 · FY2005 · MH
Imaging of Serotonin Transporters in Depression$170,846
K08 · FY2004 · MH
Imaging of Serotonin Transporters in Depression$170,349
K08 · FY2003 · MH
SPECT IMAG OF STRIAT DOPA W/ [123 I]IBZM,D AMPHET &T IN DEPRESS P$192,910
M01 · FY2002 · RR
Imaging of Serotonin Transporters in Depression$170,804
K08 · FY2002 · MH
SPECT IMAG OF STRIAT DOPA W/ [123 I]IBZM,D AMPHET &T IN DEPRESS P$192,910
M01 · FY2001 · RR
Imaging of Serotonin Transporters in Depression$171,382
K08 · FY2001 · MH
SPECT IMAG OF STRIAT DOPA W/ [123 I]IBZM,D AMPHET &T IN DEPRESS P$0
M01 · FY2001 · RR
SPECT IMAG OF STRIAT DOPA W/ [123 I]IBZM,D AMPHET &T IN DEPRESS P$0
M01 · FY2000 · RR
SPECT IMAG OF STRIAT DOPA W/ [123 I]IBZM,D AMPHET &T IN DEPRESS P$0
M01 · FY2000 · RR